Comparative studies on the secretion and activation of MMPs in two reconstructed human skin models using HaCaT- and HaCaT-ras-transfected cell lines

Clinical and Experimental Metastasis

Volumn 20, Issue 8, 2003, Pages 675-683

  Nova, D ^a   Le Griel, C ^a   Holvoet, S ^a   Gentilhomme, E ^b   Vincent, C ^a   Staquet, M J ^a   Schmitt, D ^a   Serres, M ^a,c  

^a INSERM   (France)

^b CRSSA   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Fibroblasts; HaCaT cell lines; Metalloproteinases; Normal human keratinocytes; Reconstructed human skin

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; BIOLOGICAL MODEL; CANCER INVASION; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MOTILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEPIDERMIZED DERMIS; DERMAL SUBSTITUTE; DERMIS; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; MEMBRANE STRUCTURE; PROTEIN EXPRESSION; SKIN; TISSUE REGENERATION; WOUND HEALING;

CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TRANSFORMED; COLLAGEN; ENZYME ACTIVATION; FIBROBLASTS; GENES, RAS; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; MODELS, BIOLOGICAL; SKIN; TUMOR CELLS, CULTURED;

EID: 0346250117     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CLIN.0000006816.09548.31     Document Type: Article

References (60)

1. McDougall JR, Matrisian LM. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metast Rev 1995; 14: 351-62.
2. Curran S, Murray GI. Matrix metalloproteinases in tumor invasion and metastasis. J Pathol 1999; 189: 300-8.
3. Ravanti L, Kähäri V-M. Matrix metalloproteinases in wound repair. Int J Mol Med 2000; 6: 391-407.
4. Vihinen P, Kähäri V-M. Matrix metalloproteinases in cancer: Pronostic markers and therapeutic targets. Int J Cancer 2002; 99: 157-66.
5. Kähäri V-M, Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 1997; 6: 199-213.
6. Kobayashi T, Hattori S, Nagai I et al. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatol 1998; 197: 1-5.
7. Petersen M, Woodley DT, George MD et al. Constitutive production of procollagenase and tissue inhibitor of metalloproteinases by human keratinocytes in culture. J Invest Dermatol 1989; 92: 156-9.
8. Saarialho-Kere UK, Vaalamo M, Airola K et al. Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin diseases. J Invest Dermatol 1995; 104: 982-8.
9. Pilcher BK, Dumin JA, Sudbeck BD et al. The activity of collagenase-1 is required for keratinocyte migration on a type 1 collagen matrix. J Cell Biol 1998; 137: 1445-57.
10. Petersen M, Woodley DT, Stricklin GP et al. Enhanced synthesis of collagenase by human keratinocytes cultured on type I or type IV collagen. J Invest Dermatol 1990; 94: 341-6.
11. Sudbeck BD, Pilcher BK, Welgus HG et al. Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments. J Biol Chem 1997; 272: 22103-10.
12. Charvat S, Chignol MC, Souchier C et al. Cell migration and MMP-9 secretion are increased by epidermal growth factor in HaCaT-ras transfected cells. Exp Dermatol 1998; 7: 184-90.
13. Charvat S, Le Griel C, Chignol MC et al. Ras-transfection up-regulated HaCaT cell migration: Inhibition by Marimastat. Clin Exp Metast 1999; 17: 677-85.
14. Ha-transfected immortalized human keratinocytes. Br J Cancer 1998; 77: 724-30.
15. Baumann P, Zigrino P, Mauch C et al. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes. Br J Cancer 2000; 83: 1387-93.
16. Bachmeier BE, Boukamp P, Lichtinghagen R et al. Matrix proteinases-2, -3, -7, -9 and -10, but not MMP-11, are differentially expressed in normal, begnin tumorigenic and malignant human keratinocyte cell lines. Biol Chem 2000; 381: 497-507.
17. Bachmeier BE, Nerlich AG, Boukamp P et al. Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1, -8 and -13 and of TIMP-1. Biol Chem 2000; 381: 509-17.
18. Airola K, Fusenig NE. Differential stromal regulation of MMP-1 expression in begnin and malignant keratinocytes. J Invest Dermatol 2001; 116: 85-92.
19. Borchers AH, Steinbauer H, Schafer BS et al. Fibroblast-direct expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma. Mol Carcinogenesis 1997; 19: 258-66.
20. Johansson N, Westermarck J, Hakkinen L et al. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ 1997; 8: 243-50.
21. Ikebe T, Shinohara M, Takeuchi H et al. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer. Clin Exp Metast 1999; 17: 315-23.
22. De Angelis T, Noè A, Chatterjee M et al. Stromelysin-1 activation correlates with invasiveness in squamous cell carcinoma. J Invest Dermatol 2002; 118: 759-66.
23. Dumas V, Kanitakis J, Charvat S et al. Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res 1999; 19: 2929-38.
24. Okada A, Bellocq JP, Rouyer N et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, head and neck carcinomas. Proc Natl Acad Sci USA 1995; 92: 2730-4.
25. Brummer O, Athar S, Riethorf L et al. Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in begnin and malignant breast lesions: An in situ hybridization study. Virchows Arch 1999; 435: 566-73.
26. Rao JS, Seiki M. Regulatory mechanism of 92-Da type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993; 8: 395-405.
27. Uria JA, Stahle-Bäckdahl M, Seiki M et al. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 1997; 57: 4882-8.
28. Chi Y, Zeigler ME, Walker J et al. Elaboration of matrix metalloproteinase inhibitors by human skin in organ culture and by skin cells in monolayer culture: Relationship to invasion. Invas Metastasis 1998; 18: 27-34.
29. Osborne CS, Schmid P. Epidermal-dermal interactions regulate gelatinase activity in Apligraf, a tissue-engineered human skin equivalent. Br J Dermatol 2002; 146: 26-31.
30. Moon SE, Dame MK, Remick DR et al. Induction of matrix metalloproteinase-1 (MMP-1) during epidermal invasion of the stroma in human skin organ culture: Keratinocyte stimulation of fibroblast MMP-1 production. Br J Cancer 2001; 85: 1600-5.
31. Boukamp P, Petrasevska RT, Breitkreutz D et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106: 761-71.
32. Boukamp P, Stanbridge E, Yin Foo D et al. C-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res 1990; 50: 2840-7.
33. Regnier M, Prunieras M, Woodley D. Growth and differentiation of adult human epidermal cells on dermal substrates. Front Matrix Biol 1981; 9: 4-35.
34. Shahabeddin L, Berthod F, Damour O et al. Characterization of skin reconstructed on a chitosan-cross linked collagen-glycosaminoglycan matrix. Skin Pharmacol 1990; 3: 107-14.
35. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980; 102: 196-202.
36. Netzel-Arnett S, Mallya SK, Nagase H et al. Continously recording fluorescent assays optimized for five human metalloproteinases. Anal Biochem 1991; 195: 86-92.
37. Boelsma E, Gibbs S, Faller C et al. Characterization and comparison of reconstructed skin models: Morphological and immunohistochem ical evaluation. Acta Derm Venereol 2000; 80: 82-8.
38. Schoop VM, Mirancea N, Fusenig NE. Epidermal organisation and differentiation of HaCaT keratinocytes in organotypic coculture with dermal fibroblasts. J Invest Dermatol 1999; 112: 343-53.
39. Serres M, Filhol O, Lickert H et al. The disruption of adherens junctions is associated with a decrease of E-cadherin phosphorylation by protein kinase CK2. Exp Cell Res 2000; 257: 255-64.
40. Kehe K, Abend M, Kehe K et al. Tissue engineering with HaCaT cells and a fibroblast cell line. Arch Dermatol Res 1999; 291: 600-5.
41. Ponec M, Boelsma, E, Weerheim A. Covalently bound lipids in reconstructed human epithelia. Acta Dermatol Venereol 2000; 80: 89-93.
42. Breitkreutz D, Schoop VM, Mirancea N et al. Epidermal differentiation and basement membrane formation HaCaT cells in surface transplants. Eur J Cell Biol 1998; 75: 273-86.
43. Lee D-Y, Park K-C, Cho K-H. In a skin equivalent HaCaT cells have a preserved capacity to receive melanosomes but melanocytes do not remain in the basal location. Arch Dermatol Res 2001; 293: 268-72.
44. Steinstrasser I, Koopman K, Merkle HP. Epidermal aminopeptidase activity and metabolism as observed in an organized HaCaT cell sheet model. J Pharm Sci 1997; 86: 378-83.
45. Slade N, Pavelic J, Kruslin B et al. Type IV collagenase in squamous cell and basal cell skin carcinomas. Arch Dermatol Res 1995; 287: 512-4.
46. Skobe M, Rockwell P, Goldstein N et al. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 1997; 3: 1222-7.
47. Sahuc F, Nakazawa K, Berthod F et al. Mesenchymal-epithelial interactions regulate gene expression of type VII collagen and kalinin in keratinocytes and dermal-epidermal junction formation in a skin equivalent model. Wound Rep Reg 1996; 4: 93-102.
48. Vaccariello M, Javaherian A, Wang Y et al. Cell interactions control the fate of malignant keratinocytes in an organotypic model of early neoplasia. J Invest Dermatol 1999; 113: 384-91.
49. Karelina TV, Bannikov GA, Eisen AZ. Basement membrane zone remodeling during appendageal development in human fetal skin. The absence of type VII collagen is associated with gelatinase-A (MMP-2) activity. J Invest Dermatol 2000; 114: 371-5.
50. Rosdy M, Clauss L-C. Terminal epidermal differentiation of human keratinocytes grown in chemically defined medium on inert filter substrates at the air/liquid interface. J Invest Dermatol 1990; 95: 409-14.
51. Maas-Szabowski N, Stark H-J, Fusenig NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000; 114: 1075-84.
52. Maas-Szabowski N, Szabowski A, Stark H-J et al. Organotypic cocultures with genetically modified mouse fibroblasts as a tool to dissect molecular mechanisms regulating keratinocyte growth and differentiation. J Invest Dermatol 2001; 116: 816-20.
53. McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore! Current Op Cell Biol 2001; 13: 534-40.
54. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on Batimastat and Marismastat. Pharmacol Ther 1997; 75: 69-75.
55. Lauer-Fields J, Fields GB. Matrix metalloproteinase inhibitors and cancer. Exp Opin Ther Patents 2000; 10: 1873-84.
56. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 2000; 1477: 267-83.
57. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trial and tribulations. Science 2002; 295: 2387-92.
58. Zeigler ME, Chi Y, Schmidt T et al. The role of Erk and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 1999; 180: 271-84.
59. Johansson N, Ala-aho R, Uitto V-J et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000; 113: 227-35.
60. Simon C, Simon M, Vucelic G et al. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp Cell Res 2001; 271: 344-55.